Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial.

Raal, Frederick; Fourie, Nyda; Scott, Russell; Blom, Dirk; De Vries Basson, Matthys; Kayikcioglu, Meral; Caldwell, Kate; Kallend, David; Stein, Evan

Raal, Frederick; Fourie, Nyda; Scott, Russell; Blom, Dirk; De Vries Basson, Matthys; Kayikcioglu, Meral; Caldwell, Kate; Kallend, David; Stein, Evan.

Afiliação

Raal F; Carbohydrate and Lipid Metabolism Research Unit, Department of Medicine, Division of Endocrinology and Metabolism, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, Gauteng, South Africa.
Fourie N; Iatros International, 20 Captain Proctor street , Brandwag, 9301 Bloemfontein, Free State, South Africa.
Scott R; New Zealand Clinical Research, 214 Antigua street, 8011 Christchurch, South Island, New Zealand.
Blom D; Division of Lipidology and Cape Heart Institute, Department of Medicine, University of Cape Town, 7701 Cape Town, Western Cape, South Africa.
De Vries Basson M; Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, 7530 Cape Town, Western Cape, South Africa.
Kayikcioglu M; Department of Cardiology, Ege University, 35000 Izmir, Turkey.
Caldwell K; LIB Therapeutics, Cincinnati, 45201 OH, USA.
Kallend D; LIB Therapeutics, Cincinnati, 45201 OH, USA.
Stein E; LIB Therapeutics, Cincinnati, 45201 OH, USA.

Eur Heart J ; 44(40): 4272-4280, 2023 Oct 21.

Article em En | MEDLINE | ID: mdl-37639462

Palavras-chave

Familial hypercholesterolaemia; Lerodalcibep; Low-density lipoprotein cholesterol

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google